MTOR and Adenoma sebaceum: Topical mTOR inhibitors reduced the size and improved the color of facial angiofibroma in multiple clinical trials and case reports [9–15], which was maintained over time [15–17], and was further confirmed in a post marketing surveillance conducted in Japan [18].